study htb 30tm Search Results


study htb 30tm  (ATCC)
99
ATCC study htb 30tm
Study Htb 30tm, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/study htb 30tm/product/ATCC
Average 99 stars, based on 1 article reviews
study htb 30tm - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier
skbr3  (ATCC)
99
ATCC skbr3
Time dependent growth inhibitory effect of Gluc-LiDps-ZnPP with coelenterazine on <t>SKBR3,</t> MDA-MB-231 and MRC5 cells represented at normalized absorbance at 550 nm (normalized to control). Values are mean ± SD of three independent experiments. Statistically significant differences are labeled as *** P < 0.001 and ** P < 0.01.
Skbr3, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/skbr3/product/ATCC
Average 99 stars, based on 1 article reviews
skbr3 - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

Image Search Results


Time dependent growth inhibitory effect of Gluc-LiDps-ZnPP with coelenterazine on SKBR3, MDA-MB-231 and MRC5 cells represented at normalized absorbance at 550 nm (normalized to control). Values are mean ± SD of three independent experiments. Statistically significant differences are labeled as *** P < 0.001 and ** P < 0.01.

Journal: Nanomedicine

Article Title: Listeria innocua Dps as a nanoplatform for bioluminescence based photodynamic therapy utilizing Gaussia princeps luciferase and zinc protoporphyrin IX

doi: 10.1016/j.nano.2019.04.008

Figure Lengend Snippet: Time dependent growth inhibitory effect of Gluc-LiDps-ZnPP with coelenterazine on SKBR3, MDA-MB-231 and MRC5 cells represented at normalized absorbance at 550 nm (normalized to control). Values are mean ± SD of three independent experiments. Statistically significant differences are labeled as *** P < 0.001 and ** P < 0.01.

Article Snippet: Immortal non-tumorigenic and carcinoma cells were selected for this study: SKBR3 (ATCC® HTB-30TM) and MDA-MB-231 (ATCC® HTB-26TM) breast cancer epithelial cells, with MRC5 (ATCC® CCL-171TM) fetal lung fibroblast cells (all from the American Type Tissue Collection (ATCC)) as the non-tumorogenisis control.

Techniques: Control, Labeling

Confocal images of MRC5, MDA-MB-231 and SKBR3 cells demonstrating uptake of Gluc-LiDps-ZnPP after 6 h incubation; blue fluorescence is indicative of the Gluc-LiDps-ZnPP, red fluorescence is indicative of DRAQ5 DNA stain; the overlay of Gluc-LiDps-ZnPP and DRAQ5 in the second column is shown that the Gluc-LiDps-ZnPP is primarily localized in the cytoplasm. Scale bar in all images in 20 μm.

Journal: Nanomedicine

Article Title: Listeria innocua Dps as a nanoplatform for bioluminescence based photodynamic therapy utilizing Gaussia princeps luciferase and zinc protoporphyrin IX

doi: 10.1016/j.nano.2019.04.008

Figure Lengend Snippet: Confocal images of MRC5, MDA-MB-231 and SKBR3 cells demonstrating uptake of Gluc-LiDps-ZnPP after 6 h incubation; blue fluorescence is indicative of the Gluc-LiDps-ZnPP, red fluorescence is indicative of DRAQ5 DNA stain; the overlay of Gluc-LiDps-ZnPP and DRAQ5 in the second column is shown that the Gluc-LiDps-ZnPP is primarily localized in the cytoplasm. Scale bar in all images in 20 μm.

Article Snippet: Immortal non-tumorigenic and carcinoma cells were selected for this study: SKBR3 (ATCC® HTB-30TM) and MDA-MB-231 (ATCC® HTB-26TM) breast cancer epithelial cells, with MRC5 (ATCC® CCL-171TM) fetal lung fibroblast cells (all from the American Type Tissue Collection (ATCC)) as the non-tumorogenisis control.

Techniques: Incubation, Fluorescence, Staining

ROS levels generated in SKBR3 and MDA-MB-231 cells treated with Gluc-LiDps-ZnPP and coelenterazine compared to untreated (control) cells. Values are mean ± SD of three independent experiments. Statistically significant differences are labeled as *** P < 0.001.

Journal: Nanomedicine

Article Title: Listeria innocua Dps as a nanoplatform for bioluminescence based photodynamic therapy utilizing Gaussia princeps luciferase and zinc protoporphyrin IX

doi: 10.1016/j.nano.2019.04.008

Figure Lengend Snippet: ROS levels generated in SKBR3 and MDA-MB-231 cells treated with Gluc-LiDps-ZnPP and coelenterazine compared to untreated (control) cells. Values are mean ± SD of three independent experiments. Statistically significant differences are labeled as *** P < 0.001.

Article Snippet: Immortal non-tumorigenic and carcinoma cells were selected for this study: SKBR3 (ATCC® HTB-30TM) and MDA-MB-231 (ATCC® HTB-26TM) breast cancer epithelial cells, with MRC5 (ATCC® CCL-171TM) fetal lung fibroblast cells (all from the American Type Tissue Collection (ATCC)) as the non-tumorogenisis control.

Techniques: Generated, Control, Labeling

(A) The photograph of a wound healing assay performed on SKBR3 cells. The cell migration images tracked immediately after treatment t = 0 and every 8 h thereafter. (B) The relative change of gap distance with time for SKBR3 cells as a measure of cell migration. Mean values are shown ± SD of three independent experiments.

Journal: Nanomedicine

Article Title: Listeria innocua Dps as a nanoplatform for bioluminescence based photodynamic therapy utilizing Gaussia princeps luciferase and zinc protoporphyrin IX

doi: 10.1016/j.nano.2019.04.008

Figure Lengend Snippet: (A) The photograph of a wound healing assay performed on SKBR3 cells. The cell migration images tracked immediately after treatment t = 0 and every 8 h thereafter. (B) The relative change of gap distance with time for SKBR3 cells as a measure of cell migration. Mean values are shown ± SD of three independent experiments.

Article Snippet: Immortal non-tumorigenic and carcinoma cells were selected for this study: SKBR3 (ATCC® HTB-30TM) and MDA-MB-231 (ATCC® HTB-26TM) breast cancer epithelial cells, with MRC5 (ATCC® CCL-171TM) fetal lung fibroblast cells (all from the American Type Tissue Collection (ATCC)) as the non-tumorogenisis control.

Techniques: Wound Healing Assay, Migration